Despite the fact that hydroxychloroquine is the preferred treatment therapy according to an international survey of 6,000 doctors, Ohio Representative Tavid Galonski (D) says she wants to press "crimes against humanity charges" against President Trump.
Trump has repeatedly touted the potential benefits of hydroxychloroquine.
The FDA recently approved use of the anti-malarial drug during the COVID-19 pandemic.
Medical researchers are looking into the effectiveness of the drug and clinical trials are being conducted nationwide.
While Trump hasn't said it's the only therapy that should be used, he's insisted that patients and their physicians should have the option to try the drug if they deem its appropriate.
The Surgeon General himself said he would discuss it with his doctor if he was infected with COVID-19 and needed to explore various options.
See more details including Galonski's tweet below:
The fact that hydroxychloroquine shows promising results should be exciting everyone, regardless of political party.
While scientists and researchers are searching for a potential vaccine, there is no other medication that appears to have as much traction as the anti-malarial drug.
Many governors have banned the use of the drug in their state, only to reverse their initial decisions.
The Hill confirms Galonski's comments:
Ohio state Rep. Tavia Galonski (D) said that she will make a “referral for crimes against humanity” over President Trump’s promotion of the antimalarial drug hydroxychloroquine as a treatment for the novel coronavirus, despite its unproven benefits and lack of long-term Food and Drug Administration (FDA) approval.
“I can’t take it anymore. I’ve been to The Hague. I’m making a referral for crimes against humanity tomorrow,” Galonski tweeted late Sunday.
“Today’s press conference was the last straw," Galonski added. "I know the need for a prosecution referral when I see one.”
Galonski, who represents the Akron area, told the Ohio Capital Journal on Sunday that she had "no idea” how she would go about such a referral.
“How hard can it be?” Galonski, a former magistrate in the Summit Count Common Pleas Court added.
Trump has repeatedly promoted hydroxychloroquine, which is approved to treat conditions like rheumatoid arthritis and lupus, as a potential treatment for the coronavirus, which the FDA said last week has led to a shortage of the drug.
If Galonski moves forward to file an official crimes against humanity charge, she will be yet another Democrat making moves to undermine the president.
Speaker Pelosi has already given a committee the power to subpoena the Trump administration over the handling of coronavirus stimulus funds, as well as the response itself.
There have been numerous examples of patients who thought they were going to die who have recovered after trying hydroxychloroquine.
While this does not mean that the medication is an end-all-be-all solutions, patients and their doctors should have the right to try it if it appears to be their best option.
There have been shortages of hydroxychloroquine across the country as hospitals and healthcare providers attempt to get their hands on the medication.
The FDA has already approved temporary use of the drug for patients hospitalized with COVID-19.
Production of the anti-maliarial drug is increasing, so these shortages should soon disappear.
Newsweek confirms the FDA's decision and has more on their explanation to approve the drug:
The U.S. is facing shortages of antimalarial drugs being used experimentally to treat COVID-19 patients, according to the Food and Drug Administration (FDA).
Both hydroxychloroquine and chloroquine, which are used to treat malaria, lupus and rheumatoid arthritis, are listed as "currently in shortage" by the agency. This is "due to a significant surge in demand," the body said.
The FDA stated: "all manufacturers are ramping up production" and the agency is ensuring this is happening "expeditiously and safely."
The announcement follows FDA approval of the drugs for use in patients hospitalized by and in clinical trials for the treatment of COVID-19, after it issued the first Emergency Use Authorization for a drug related to the disease over the weekend.
The U.S. Department of Health and Human Services (HHS) said in a statement on Sunday that it accepted 30 million doses of hydroxychloroquine sulfate from an arm of the pharmaceutical company Novartis, and one million of chloroquine phosphate from Bayer Pharmaceuticals.
On Wednesday, the FDA said the 30 million doses "is expected to help ease supply pressures for the drugs.
"This is a fluctuating and dynamic situation and the FDA is actively engaged. The agency is updating its shortages lists regularly and continuing to communicate in real-time so that patients and healthcare providers have the most current information on product shortages in the U.S."
Explaining the reasoning behind the FDA giving the green light for the medications on Sunday, the HHS said: "Anecdotal reports suggest that these drugs may offer some benefit in the treatment of hospitalized COVID-19 patients. Clinical trials are needed to provide scientific evidence that these treatments are effective."
President Trump has surrounded himself by experts and is listening to their advice.
Dr. Fauci himself lauded Trump's ability to listen to the experts, even if he personally disagrees with them.
The president isn't promoting the potential benefits of hydroxychloroquine out of nowhere.
It is the preferred medicine against COVID-19 according to an international survey of 6,000 doctors from over 30 countries.
Perhaps Representative Galonski should listen to the science before trying to undermine the President of the United States.
See some reactions from Twitter below: